Meryl Horne

In that case, it was on people who were addicted to cocaine and they had less cravings.

But then I chatted with Paul about the dose that they were giving and

It says that they received a dose of 1,800 milligrams.

So that's like 10 times more than what you were giving.

So would you say that was actually pretty dangerous?

By the way, I did reach out to those researchers to ask about the danger here and didn't hear back.

Yeah.

In about half of those deaths, it looked like there was some other issue that had like a comorbidity that might explain like that predisposed people to like cardiac risks.

But in the other half, they didn't see that.

So we're still not sure why it's sometimes killing people.

And, you know, I think scientists might find a way to get that benefit for addiction without the cardiac risks.

Like, I talked to a different scientist who is doing clinical trials right now to find out if maybe we can, like, space out the dosing to find a sweet spot.

And Paul's also hopeful that something like that can work.

But...

We're not there yet.

And on top of all that, there's another issue that came up while I was doing this research.

I found that in some of those observational studies that work with Ibogaine clinics, like the one Alan worked with, they're actually giving people another psychedelic along with the Ibogaine.

So, yeah, a couple of days after their Ibogaine trips, they'll often get DMT.

Oh, is that what happened with Holly and Rett?

Well, Holly didn't go to one of these clinics and didn't have a DMT.